Fig. 2.
Prevalence of pre-treatment drug resistance mutations among the participants initiating ART and enrolled in the 2008–2010 HIV drug resistance survey
Prevalence of pre-treatment drug resistance mutations among the participants initiating ART and enrolled in the 2008–2010 HIV drug resistance survey